Ileus medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 19: Line 19:
*** Preferred regimen (3): Add [[oxycodone]] 5 to 10 mg [[Orally ingested|orally]] every three hours as needed for [[breakthrough pain]].
*** Preferred regimen (3): Add [[oxycodone]] 5 to 10 mg [[Orally ingested|orally]] every three hours as needed for [[breakthrough pain]].
*** Preferred regimen (4): [[Hydromorphone]] 0.2 to 0.5 mg IV every four hours as needed for severe breakthrough pain not responsive to [[oral]] medications.
*** Preferred regimen (4): [[Hydromorphone]] 0.2 to 0.5 mg IV every four hours as needed for severe breakthrough pain not responsive to [[oral]] medications.
**1.1.2 '''Fluid replacement'''
**1.2 '''Fluid replacement'''
*** Preferred regimen (1): [[Isotonic]] [[saline]] (1 to 2 liters) to relieve symptoms.
*** Preferred regimen (1): [[Isotonic]] [[saline]] (1 to 2 liters) to relieve symptoms.
***: '''Note (1):''' Rapid infusion of [[isotonic]] [[fluid]] is advised until symptoms resolve.
***: '''Note (1):''' Rapid infusion of [[isotonic]] [[fluid]] is advised until symptoms resolve.
**'''1.3 -'''Recurrent vomiting or Abdominal distension'''
*** Preferred regimen (1): Nasogastric (NG) tube placement until symptoms resolve
***: '''Note (1):''' The tip of NG tube should be placed in the stomach.
***: '''Note (2):''' To prevent fluid loss, volume of fluid removed should be replaced with isotonic saline.


===Contraindicated medications===
===Contraindicated medications===

Revision as of 18:43, 1 February 2018

Ileus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ileus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ileus medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ileus medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ileus medical therapy

CDC on Ileus medical therapy

Ileus medical therapy in the news

Blogs on Ileus medical therapy

Directions to Hospitals Treating Ileus

Risk calculators and risk factors for Ileus medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

The majority of cases of ileus are resolved with correction of underlying electrolyte disorder and only require supportive care. Intravenous hydration is advised with appropriate rapid supplementation for electrolyte abnormalities. NSAID are used as baseline analgesic medications and opiates are used in case of severe intractable pain. Patients are put on NPO and nasogastric tube to relieve recurrent vomiting or abdominal distention associated with pain. Prokinetic agents such as erythromycin are not routinely recommended.

Medical Therapy

Medical therapy for ileus includes correcting the underlying condition and supportive therapy.[1][2][3]

  • Patients should receive intravenous hydration.
  • Patients of ileus from electrolyte abnormalities should be treated with appropriate supplementation.
  • Bowel rest and nasogastric decompression can relieve recurrent vomiting or abdominal distention associated with pain.[4][5]
  • Antimotility drugs and other medications (narcotics) which may alter intestinal motility should be stopped.
  • Prokinetic agents such as erythromycin are not routinely recommended.
    • 1.1 - Post-operative pain
      • Preferred regimen (1): Acetaminophen 1000 mg orally every six hours (or IV incase patient is NPO).
      • Preferred regimen (2): Add diclofenac 50 mg orally twice a day with meals for two days and adjust as-needed.
      • Preferred regimen (3): Add oxycodone 5 to 10 mg orally every three hours as needed for breakthrough pain.
      • Preferred regimen (4): Hydromorphone 0.2 to 0.5 mg IV every four hours as needed for severe breakthrough pain not responsive to oral medications.
    • 1.2 Fluid replacement
      • Preferred regimen (1): Isotonic saline (1 to 2 liters) to relieve symptoms.
        Note (1): Rapid infusion of isotonic fluid is advised until symptoms resolve.
    • 1.3 -Recurrent vomiting or Abdominal distension
      • Preferred regimen (1): Nasogastric (NG) tube placement until symptoms resolve
        Note (1): The tip of NG tube should be placed in the stomach.
        Note (2): To prevent fluid loss, volume of fluid removed should be replaced with isotonic saline.

Contraindicated medications

Paralytic ileus is considered an absolute contraindication to the use of the following medications:

References

  1. Bruns BR, Kozar RA (2016). "Feeding the Postoperative Patient on Vasopressor Support: Feeding and Pressor Support". Nutr Clin Pract. 31 (1): 14–7. doi:10.1177/0884533615619932. PMID 26703957.
  2. Cali RL, Meade PG, Swanson MS, Freeman C (2000). "Effect of Morphine and incision length on bowel function after colectomy". Dis. Colon Rectum. 43 (2): 163–8. PMID 10696888.
  3. Wu Z, Boersema GS, Dereci A, Menon AG, Jeekel J, Lange JF (2015). "Clinical endpoint, early detection, and differential diagnosis of postoperative ileus: a systematic review of the literature". Eur Surg Res. 54 (3–4): 127–38. doi:10.1159/000369529. PMID 25503902.
  4. Kehlet H, Williamson R, Büchler MW, Beart RW (2005). "A survey of perceptions and attitudes among European surgeons towards the clinical impact and management of postoperative ileus". Colorectal Dis. 7 (3): 245–50. doi:10.1111/j.1463-1318.2005.00763.x. PMID 15859962.
  5. Kehlet H, Büchler MW, Beart RW, Billingham RP, Williamson R (2006). "Care after colonic operation--is it evidence-based? Results from a multinational survey in Europe and the United States". J. Am. Coll. Surg. 202 (1): 45–54. doi:10.1016/j.jamcollsurg.2005.08.006. PMID 16377496.